{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:31:50Z","timestamp":1793035910783,"version":"4.5.0"},"reference-count":185,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.semarthrit.2020.06.015","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T19:29:11Z","timestamp":1593545351000},"page":"1089-1100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Advances in our understanding of gout as an auto-inflammatory disease"],"prefix":"10.1016","volume":"50","author":[{"given":"Shari","family":"Bodofsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony R.","family":"Merriman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Schlesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0001","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/acr.21791","article-title":"mass index, obesity, and prevalent gout in the United States in 1988\u20131994 and 2007\u20132010","volume":"65","author":"Juraschek","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.015_bib0002","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.amjmed.2010.09.012","article-title":"et al. Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout","volume":"124","author":"Keenan","year":"2011","journal-title":"Am. J. Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.015_bib0003","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/hmg\/ddp489","article-title":"et al. Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms","volume":"19","author":"van der Harst","year":"2010","journal-title":"Hum. Mol. Genet"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.015_bib0004","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","article-title":"Asymptomatic hyperuricemia. Risks and consequences in the normative aging study","volume":"82","author":"Campion","year":"1987","journal-title":"Am. J. Med"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.06.015_bib0005","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/annrheumdis-2017-212288","article-title":"Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis","volume":"77","author":"Dalbeth","year":"2018","journal-title":"Ann. Rheum. Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.015_bib0006","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0952-7915(00)00124-2","article-title":"TNFRSF1A mutations and autoinflammatory syndromes","volume":"12","author":"Galon","year":"2000","journal-title":"Curr. Opin. Immunol"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.015_bib0007","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.015_bib0008","doi-asserted-by":"crossref","first-page":"AB227","DOI":"10.1016\/j.jaci.2010.12.902","article-title":"et al. Canakinumab Reduces The Risk Of Acute Gouty Arthritis Flares During Initiation Of Allopurinol Therapy: results Of A Double-blind, Randomised Study","volume":"127","author":"Schlesinger","year":"2011","journal-title":"J. Allergy Clin. Immunol"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.06.015_bib0009","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41588-019-0504-x","article-title":"Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels","volume":"51","author":"Tin","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0010","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddaa013","article-title":"et al. Genomic dissection of 43 serum urate-associated loci provides multiple insights into molecular mechanisms of urate control","author":"Boocock","year":"2020","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0011","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s42003-019-0339-0","article-title":"et al. Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals","volume":"2","author":"Nakatochi","year":"2019","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0012","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/annrheumdis-2014-205877","article-title":"Twenty-eight loci that influence serum urate levels: analysis of association with gout","volume":"75","author":"Phipps-Green","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.015_bib0013","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41584-018-0004-x","article-title":"An update on the genetics of hyperuricaemia and gout","volume":"14","author":"Major","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0014","article-title":"The Works of Thomas Sydndenham, MD on Acute and Chronic Diseases. A Treatise of the Gout and Dropsy. Vol II. G","author":"Syndenham","year":"1853","journal-title":"J. & J. Robinson"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.06.015_bib0015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat. Rev. Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.015_bib0016","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ng.106","article-title":"et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout","volume":"40","author":"Veronique","year":"2008","journal-title":"Nat. Genet"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0017","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/ng.107","article-title":"et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects","volume":"40","author":"Doring","year":"2008","journal-title":"Nat. Genet"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0018","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ajhg.2007.11.001","article-title":"et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia","volume":"82","author":"Wallace","year":"2008","journal-title":"Am. J. Hum. Genet"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0019","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(08)61343-4","article-title":"et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study","volume":"372","author":"Dehghan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0020","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1371\/journal.pgen.0030194","article-title":"et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts","volume":"3","author":"Li","year":"2007","journal-title":"PLoS Genet"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0021","doi-asserted-by":"crossref","first-page":"e1948","DOI":"10.1371\/journal.pone.0001948","article-title":"et al. Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study","volume":"3","author":"Stark","year":"2008","journal-title":"PLoS ONE"},{"issue":"13","key":"10.1016\/j.semarthrit.2020.06.015_bib0022","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1073\/pnas.1214530110","article-title":"et al. Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules","volume":"110","author":"Woodward","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0023","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/1874312901812010094","article-title":"Multiple Membrane Transporters and Some Immune Regulatory Genes are Major Genetic Factors to Gout","volume":"12","author":"Zhu","year":"2018","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0024","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCGENETICS.109.934455","article-title":"et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors","volume":"3","author":"Yang","year":"2010","journal-title":"Circ. Cardiovasc. Genet"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0025","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13075-015-0609-2","article-title":"An update on the genetic architecture of hyperuricemia and gout","volume":"17","author":"Merriman","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.06.015_bib0026","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/rheumatology\/kem235","article-title":"The polymorphism -863C\/A in tumour necrosis factor-alpha gene contributes an independent association to gout","volume":"46","author":"Chang","year":"2007","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.015_bib0027","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/03009742.2012.726372","article-title":"IL-8 -251T\/A and IL-12B 1188A\/C polymorphisms are associated with gout in a Chinese male population","volume":"42","author":"Liu","year":"2013","journal-title":"Scand. J. Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.06.015_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064845","article-title":"et al. Association of TLR4 Gene rs2149356 polymorphism with primary gouty arthritis in a case-control study","volume":"8","author":"Qing","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0029","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2019-216233","article-title":"et al. Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout","author":"Kl\u00fcck","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.015_bib0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/annrheumdis-2017-212416","article-title":"et al. Mitochondrial genetic variation and gout in M\u0101ori and Pacific people living in Aotearoa New Zealand","volume":"77","author":"Gosling","year":"2018","journal-title":"Ann. Rheum. Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0031","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11926-001-0049-7","article-title":"Pathogenesis of crystal-induced inflammation","volume":"3","author":"Landis","year":"2001","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0032","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1084\/jem.124.1.115","article-title":"Crystal-induced inflammation in canine joints: II. Importance of polymorphonuclear leukocytes","volume":"124","author":"Phelps","year":"1966","journal-title":"J. Exp. Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.015_bib0033","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","article-title":"Preliminary criteria for the classification of the acute arthritis of primary gout","volume":"20","author":"Wallace","year":"1977","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.06.015_bib0034","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780280911","article-title":"Crystal-induced endogenous pyrogen production. A further look at gouty inflammation","volume":"28","author":"Malawista","year":"1985","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/art.1780360118","article-title":"Superoxide anion production and phagocytosis of crystals by cultured endothelial cells","volume":"36","author":"Falasca","year":"1993","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0036","first-page":"102","article-title":"Urate crystal induced inflammation in dog joints: sequence of synovial changes","volume":"1","author":"Schumacher","year":"1974","journal-title":"J. Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.015_bib0037","first-page":"291","article-title":"Monosodium urate crystal-induced prostaglandin synthesis in the rat subcutaneous air pouch","volume":"3","author":"Gordon","year":"1985","journal-title":"Clin. Exp. Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0038","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1172\/JCI28075","article-title":"et al. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals","volume":"116","author":"Chen","year":"2006","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0039","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signaling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.06.015_bib0040","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","article-title":"Inflammation in gout: mechanisms and therapeutic targets","volume":"13","author":"So","year":"2017","journal-title":"Nat. Rev. Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0041","first-page":"39","article-title":"The role of the NLRP3 inflammasome in gout","volume":"4","author":"Kingsbury","year":"2011","journal-title":"J. Inflamm. Res"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0042","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0952-7915(02)00017-1","article-title":"New insights into the mechanism of IL-1[beta] maturation","volume":"15","author":"Burns","year":"2003","journal-title":"Curr. Opin. Immunol"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0043","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/art.21238","article-title":"Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation","volume":"52","author":"Liu-Bryan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0044","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0045","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.it.2017.01.003","article-title":"Recent insights into the molecular mechanisms underlying pyroptosis and gasdermin family functions","volume":"38","author":"Aglietti","year":"2017","journal-title":"Trends Immunol"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.06.015_bib0046","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/rheumatology\/keh640","article-title":"Mechanisms of inflammation in gout","volume":"44","author":"Dalbeth","year":"2005","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.015_bib0047","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00011-011-0427-1","article-title":"TLR4 polymorphisms and disease susceptibility","volume":"61","author":"Noreen","year":"2012","journal-title":"Inflamm. Res"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0048","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147939","article-title":"et al. The Toll-Like Receptor 4 (TLR4) variant rs2149356 and risk of gout in European and Polynesian sample sets","volume":"11","author":"Rasheed","year":"2016","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.06.015_bib0049","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/art.21238","article-title":"Innate immunity conferred by toll\u2010like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal\u2013induced inflammation","volume":"52","author":"Liu\u2010Bryan","year":"2005","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0050","first-page":"233","article-title":"Monosodium urate crystal interleukin-1\u03b2 release is dependent on Toll-like receptor 4 and transient receptor potential V1 activation","volume":"59","author":"Rossato","year":"2019","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.015_bib0051","first-page":"G1167","article-title":"A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis","volume":"296","author":"Ungaro","year":"2009","journal-title":"Am. J. Physiol"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2014.12.001","article-title":"Toll-like receptor 4 inhibition reduces vascular inflammation in spontaneously hypertensive rats","volume":"122","author":"Bomfim","year":"2015","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.015_bib0053","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00296-013-2856-3","article-title":"Changes in toll-like receptor (TLR)4\u2013NF\u03baB\u2013IL1\u03b2 signaling in male gout patients might be involved in the pathogenesis of primary gouty arthritis","volume":"34","author":"Qing","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0054","series-title":"Biology and role in the pathogenesis of disease","author":"Wu","year":"2019"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.06.015_bib0055","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.4049\/jimmunol.177.9.6370","article-title":"Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals","volume":"177","author":"Scott","year":"2006","journal-title":"J. Immunol"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0056","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7143241","article-title":"et al. Decreased Expression of CD14 in MSU-Mediated Inflammation May Be Associated with Spontaneous Remission of Acute Gout","author":"Duan","year":"2019","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0057","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s13075-015-0802-3","article-title":"et al. Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout","volume":"17","author":"McKinney","year":"2015","journal-title":"Arthritis Res. Ther"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.06.015_bib0058","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.4049\/jimmunol.167.10.5838","article-title":"et al. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity","volume":"167","author":"LeVan","year":"2001","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.semarthrit.2020.06.015_bib0059","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00109-009-0479-7","article-title":"et al. Functional impact of endotoxin receptor CD14 polymorphisms on transcriptional activity","volume":"87","author":"Mertens","year":"2009","journal-title":"J. Mol. Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.015_bib0060","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2007.08.050","article-title":"Association between CD14 polymorphisms and serum soluble CD14 levels: effect of atopy and endotoxin inhalation","volume":"121","author":"LeVan","year":"2008","journal-title":"J. Allergy Clin. Immunol"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.06.015_bib0061","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1165\/ajrcmb.20.5.3494","article-title":"A Polymorphism* in the 5\u2032 flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E","volume":"20","author":"Baldini","year":"1999","journal-title":"Am. J. Respir. Cell Mol. Biol"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.06.015_bib0062","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.1944","article-title":"IL-37 is a fundamental inhibitor of innate immunity","volume":"11","author":"Nold","year":"2010","journal-title":"Nat. Immunol"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.06.015_bib0063","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.4049\/jimmunol.180.8.5477","article-title":"The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines","volume":"180","author":"Sharma","year":"2008","journal-title":"J. Immunol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0064","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/imr.12605","article-title":"Suppression of inflammation and acquired immunity by IL\u201037","volume":"281","author":"Cavalli","year":"2018","journal-title":"Immunol. Rev"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.06.015_bib0065","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s10067-015-3109-5","article-title":"IL-37 inhibits the production of pro-inflammatory cytokines in MSU crystal-induced inflammatory response","volume":"35","author":"Zeng","year":"2016","journal-title":"Clin. Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0066","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s13075-016-1167-y","article-title":"et al. Interleukin 37 limits monosodium urate crystal-induced innate immune responses in human and murine models of gout","volume":"18","author":"Liu","year":"2016","journal-title":"Arthritis Res. Ther"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0067","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cmet.2006.05.011","article-title":"Oxidative metabolism and PGC-1\u03b2 attenuate macrophage-mediated inflammation","volume":"4","author":"Vats","year":"2006","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.015_bib0068","first-page":"457","article-title":"Genetic variants of PPAR-gamma coactivator 1B augment NLRP3-mediated inflammation in gouty arthritis","volume":"56","author":"Chang","year":"2017","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0069","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/art.10709","article-title":"Rapid induction of peroxisome proliferator-activated receptor gamma expression in human monocytes by monosodium urate monohydrate crystals","volume":"48","author":"Akahoshi","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.015_bib0070","first-page":"323","article-title":"PPARGC1B: insight into the expression of the gouty inflammation phenotype: PPARGC1B and gouty inflammation","volume":"56","author":"Merriman","year":"2017","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.015_bib0071","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4168\/aair.2014.6.6.496","article-title":"Novel genes in human asthma based on a mouse model of allergic airway inflammation and human investigations","volume":"6","author":"Temesi","year":"2014","journal-title":"Allergy Asthma Immunol. Res"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.015_bib0072","first-page":"347","article-title":"Gene structure and chromosomal localization of the human P2\u00d77 receptor","volume":"5","author":"Buell","year":"1998","journal-title":"Recept. Channels"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.015_bib0073","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nm.2710","article-title":"Genetically determined P2\u00d77 receptor pore formation regulates variability in chronic pain sensitivity","volume":"18","author":"Sorge","year":"2012","journal-title":"Nat. Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.015_bib0074","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/jnc.13078","article-title":"Functional characterization of mutants in the transmembrane domains of the rat P2\u00d77 receptor that regulate pore conductivity and agonist sensitivity","volume":"133","author":"Jindrichova","year":"2015","journal-title":"J. Neurochem"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.015_bib0075","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1074\/jbc.M507816200","article-title":"A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2\u00d77 function and impairs ATP-induced mycobacterial killing by macrophages","volume":"281","author":"Shemon","year":"2006","journal-title":"Biol. Chem"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.015_bib0076","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.4049\/jimmunol.172.6.3399","article-title":"Glu496 to Ala polymorphism in the P2\u00d77 receptor impairs ATP-induced IL-1\u03b2 release from human monocytes","volume":"172","author":"Sluyter","year":"2004","journal-title":"J. Immunol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0077","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2172-13-64","article-title":"The P2\u00d77 loss-of-function Glu496Ala polymorphism affects ex vivo cytokine release and protects against the cytotoxic effects of high ATP-levels","volume":"13","author":"Wesselius","year":"2012","journal-title":"BMC Immunol."},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0078","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1159\/000086036","article-title":"The P2\u00d77 ATP receptor in the kidney: a matter of life or death?","volume":"101","author":"Hillman","year":"2005","journal-title":"Nephron Experimental nephrology"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.015_bib0079","doi-asserted-by":"crossref","first-page":"C286","DOI":"10.1152\/ajpcell.00070.2003","article-title":"Essential role for Ca2+ in regulation of IL-1\u03b2 secretion by P2\u00d77 nucleotide receptor in monocytes, macrophages, and HEK-293 cells","volume":"285","author":"Gudipaty","year":"2003","journal-title":"J. Physiol. Cell Physiol"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.015_bib0080","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.semarthrit.2013.04.007","article-title":"P2\u00b47R: A potential key regulator of acute gouty arthritis","volume":"43","author":"Tao","year":"2013","journal-title":"Seminars in Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0081","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1074\/jbc.M006781200","article-title":"Altered cytokine production in mice lacking P2\u00d77Receptors","volume":"276","author":"Solle","year":"2001","journal-title":"Biol. Chem"},{"issue":"12","key":"10.1016\/j.semarthrit.2020.06.015_bib0082","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.4049\/jimmunol.168.12.6436","article-title":"Absence of the P2\u00d77 receptor alters leukocyte function and attenuates an inflammatory response","author":"Labasi","year":"2002","journal-title":"J. Immunol"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.06.015_bib0083","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1074\/jbc.M104388200","article-title":"Priming of macrophages with lipopolysaccharide potentiates P2\u00d77-mediated cell death via a caspase-1-dependent mechanism, independently of cytokine production","volume":"277","author":"Le Feuvre","year":"2002","journal-title":"Biol. Chem"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.015_bib0084","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/mcne.2001.1054","article-title":"(P2\u00d77) receptor activation of microglia induces cell death via an interleukin-1-independent mechanism","volume":"19","author":"Brough","year":"2002","journal-title":"Mol. Cell. Neurosci"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.06.015_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181685","article-title":"Single nucleotide polymorphisms associated with P2\u00d77R function regulate the onset of gouty arthritis","volume":"12","author":"Tao","year":"2017","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.06.015_bib0086","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3346\/jkms.2016.31.10.1566","article-title":"Genetic Association for P2\u00d77R rs3751142 and CARD8 rs2043211 Polymorphisms for Susceptibility of Gout in Korean Men: multi-Center Study","volume":"31","author":"Lee","year":"2016","journal-title":"J. Korean Med. Sci"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.06.015_bib0087","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ceca.2011.08.002","article-title":"Gain-of-function of P2\u00d77 receptor gene variants in multiple sclerosis","volume":"50","author":"Oyanguren-Desez","year":"2011","journal-title":"Cell Calcium"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.015_bib0088","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1074\/jbc.M006814200","article-title":"ATP-stimulated release of interleukin (IL)-1\u03b2 and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage","volume":"276","author":"Mehta","year":"2001","journal-title":"Biol. Chem"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.06.015_bib0089","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/sj.bjp.0702732","article-title":"Pharmacological characterization of ATP\u2010and LPS\u2010induced IL\u20101\u03b2 release in human monocytes","volume":"127","author":"Grahames","year":"1999","journal-title":"Br. J. Pharmacol"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.015_bib0090","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.4049\/jimmunol.1002720","article-title":"Differential expression of NLRP3 among hematopoietic cells","volume":"186","author":"Guarda","year":"2011","journal-title":"J. Immunol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0091","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13075-018-1664-2","article-title":"NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis","volume":"20","author":"Marchetti","year":"2018","journal-title":"Arthritis Res. Ther"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0092","series-title":"The NLRP3 inflammasome-interleukin 1 pathway as a therapeutic target in gout","author":"Szekanecz","year":"2019"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.06.015_bib0093","first-page":"13747","article-title":"rs3806268 of NLRP3 gene polymorphism is associated with the development of primary gout","volume":"8","author":"Deng","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0094","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10067-017-3900-6","article-title":"Association of NLRP3 polymorphisms with susceptibility to primary gouty arthritis in a Chinese Han population","volume":"37","author":"Zhang","year":"2018","journal-title":"Clin. Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.015_bib0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jbspin.2017.02.009","article-title":"Clinical significance of serum NLRP3 levels in patients with chronic gouty arthritis","volume":"85","author":"Choe","year":"2018","journal-title":"Joint, bone, spine: revue du rhumatisme"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.06.015_bib0096","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1007\/s10067-018-4149-4","article-title":"Study on the expressions of NLRP3 gene transcript variants in peripheral blood monocytes of primary gout patients","volume":"37","author":"Dang","year":"2018","journal-title":"Clin. Rheumatol"},{"issue":"2015","key":"10.1016\/j.semarthrit.2020.06.015_bib0097","article-title":"Role of Genetic Alterations in the and Genes in Health and Disease","volume":"10","author":"Paramel","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.015_bib0098","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1159\/000373960","article-title":"CARD8 rs2043211 Polymorphism is Associated with Gout in a Chinese Male Population","volume":"35","author":"Chen","year":"2015","journal-title":"Cell. Physiol. Biochem"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.015_bib0099","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/ard.2008.106989","article-title":"CARD8 p. C10X polymorphism is associated with inflammatory activity in early rheumatoid arthritis","volume":"69","author":"Kastbom","year":"2010","journal-title":"Ann. Rheum. Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.015_bib0100","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00011-017-1119-2","article-title":"Polymorphisms and expression of inflammasome genes are associated with the development and severity of rheumatoid arthritis in Brazilian patients","volume":"67","author":"Addobbati","year":"2018","journal-title":"Inflamm. Res"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.015_bib0101","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1515\/jomb-2016-0008","article-title":"NLRP3 and CARD8 polymorphisms influence higher disease activity in rheumatoid arthritis","volume":"35","author":"Jenko","year":"2016","journal-title":"J Med Biochem"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.015_bib0102","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1053\/j.gastro.2006.08.008","article-title":"TUCAN (CARD8) genetic variants and inflammatory bowel disease","volume":"131","author":"McGovern","year":"2006","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.06.015_bib0103","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3109\/08916934.2015.1045581","article-title":"Is the CARD8 rs2043211 polymorphism associated with susceptibility to Crohn's disease? A meta-analysis","volume":"48","author":"Zhang","year":"2015","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.015_bib0104","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/08820139.2014.988721","article-title":"Association between CARD8 rs2043211 polymorphism and inflammatory bowel disease: a meta-analysis","volume":"44","author":"Liu","year":"2015","journal-title":"Immunol. Invest"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.015_bib0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/gene.2010.11","article-title":"Evidence of interaction of CARD8 rs2043211 with NALP3 rs35829419 in Crohn's disease","volume":"11","author":"Roberts","year":"2010","journal-title":"Genes Immun"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.015_bib0106","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/jhg.2010.170","article-title":"et al. Association of CARD8 with inflammatory bowel disease in Koreans","volume":"56","author":"Yang","year":"2011","journal-title":"J. Hum. Genet."},{"issue":"12","key":"10.1016\/j.semarthrit.2020.06.015_bib0107","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/exd.12049","article-title":"Genetic support for the role of the NLRP 3 inflammasome in psoriasis susceptibility","volume":"21","author":"Carlstr\u00f6m","year":"2012","journal-title":"Exp. Dermatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.015_bib0108","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cytogfr.2011.10.001","article-title":"Understanding the mechanism of IL-1\u03b2 secretion","volume":"22","author":"Lopez-Castejon","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.015_bib0109","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1084\/jem.182.6.2019","article-title":"Inflammatory microcrystals differentially regulate the secretion of macrophage inflammatory protein 1 and interleukin 8 by human neutrophils: a possible mechanism of neutrophil recruitment to sites of inflammation in synovitis","volume":"182","author":"Hachicha","year":"1995","journal-title":"J. Exp. Med"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.06.015_bib0110","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1002\/art.27667","article-title":"Engagement of fatty acids with toll\u2010like receptor 2 drives interleukin\u20101\u03b2 production via the ASC\/caspase 1 pathway in monosodium urate monohydrate crystal\u2013induced gouty arthritis","volume":"62","author":"Joosten","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0111","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fphar.2017.00010","article-title":"C5a regulates IL-1\u03b2 production and leukocyte recruitment in a murine model of monosodium urate crystal-induced peritonitis","volume":"8","author":"Khameneh","year":"2017","journal-title":"Front. Pharmacol"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.015_bib0112","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/tpj.2017.31","article-title":"Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasis","volume":"18","author":"Loft","year":"2018","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0113","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/jre.12181","article-title":"Association of interleukin\u20101 gene variations with moderate to severe chronic periodontitis in multiple ethnicities","volume":"50","author":"Wu","year":"2015","journal-title":"J. Periodont. Res."},{"issue":"12","key":"10.1016\/j.semarthrit.2020.06.015_bib0114","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/rheumatology\/ken374","article-title":"Interleukin-1 promoter region polymorphism role in rheumatoid arthritis: a meta-analysis of IL-1B-511A\/G variant reveals association with rheumatoid arthritis","volume":"47","author":"Harrison","year":"2008","journal-title":"Rheumatology"},{"issue":"suppl_1","key":"10.1016\/j.semarthrit.2020.06.015_bib0115","first-page":"i12","article-title":"The role of IL-1 in gout: from bench to bedside","volume":"57","author":"So","year":"2018","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.06.015_bib0116","doi-asserted-by":"crossref","first-page":"535","DOI":"10.7326\/M18-1167","article-title":"Relationship of interleukin-1\u03b2 blockade with incident gout and serum uric acid levels: exploratory analysis of a randomized controlled trial","volume":"169","author":"Solomon","year":"2018","journal-title":"Ann. Intern. Med"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.06.015_bib0117","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/rheumatology\/key402","article-title":"Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial","volume":"58","author":"Janssen","year":"2019","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.06.015_bib0118","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1586\/1744666X.2014.894886","article-title":"The CXCL8\/IL-8 chemokine family and its receptors in inflammatory diseases","volume":"10","author":"Russo","year":"2014","journal-title":"Expert Rev. Clin. Immunol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0119","first-page":"1","article-title":"Associations between interleukin and interleukin receptor gene polymorphisms and risk of gout","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep"},{"issue":"12","key":"10.1016\/j.semarthrit.2020.06.015_bib0120","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1002\/art.39318","article-title":"Gout is a chronic inflammatory disease in which high levels of interleukin 8 (CXCL8), myeloid-related protein 8\/myoloid related protein 14 complex, and an altered proteome associated with diabetes mellitus and cardiovascular disease","volume":"67","author":"Kienhorst","year":"2015","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.015_bib0121","doi-asserted-by":"crossref","DOI":"10.4238\/gmr15048511","article-title":"Role of IL-8 rs4073 and rs2227306 polymorphisms in the development of primary gouty arthritis in a Chinese population","volume":"15","author":"Cui","year":"2016","journal-title":"Genet Mol Res"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.06.015_bib0122","first-page":"13432","article-title":"Association analysis between genetic variants in interleukin genes among different populations with hyperuricemia in Xinjiang Autonomous Region","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.015_bib0123","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijcard.2007.02.012","article-title":"Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease","volume":"124","author":"Inoue","year":"2008","journal-title":"Int. J. Cardiol"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0124","first-page":"636","article-title":"Proinflammatory cytokine gene polymorphisms in bullous pemphigoid","volume":"10","author":"Tabatabaei-Panah","year":"2019","journal-title":"Front. Microbiol"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.015_bib0125","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00408-017-0058-6","article-title":"IL-8 gene variants and expression in childhood asthma","volume":"195","author":"Charrad","year":"2017","journal-title":"Lung"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.06.015_bib0126","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/art.1780340716","article-title":"Monocyte\u2010derived neutrophil chemotactic factor\/interleukin\u20108 is a potential mediator of crystal\u2010induced inflammation","volume":"34","author":"Terkeltaub","year":"1991","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.06.015_bib0127","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm.3895","article-title":"IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases","volume":"21","author":"Teng","year":"2015","journal-title":"Nat. Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0128","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/cei.12563","article-title":"Association of polymorphisms in interleukin (IL)\u201012 A and\u2010B genes with rheumatoid arthritis in a Chinese population","volume":"180","author":"Wang","year":"2015","journal-title":"Clin. Exp. Immunol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0129","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5114\/ceji.2019.84019","article-title":"Ankylosing spondylitis: analysis of gene-gene interactions between IL-12\u03b2, JAK2, and STAT3 in Han Chinese and Algerian cohorts","volume":"44","author":"Saadi","year":"2019","journal-title":"Cent Eur J Immunol"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.06.015_bib0130","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00251-013-0721-x","article-title":"IL12B and IL23R gene SNPs in Japanese psoriasis","volume":"65","author":"Oka","year":"2013","journal-title":"Immunogenetics"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.015_bib0131","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00403-009-0986-y","article-title":"Genetic evidence for involvement of the IL23 pathway in Thai psoriatics","volume":"302","author":"Nair","year":"2010","journal-title":"Arch. Dermatol. Res."},{"issue":"12","key":"10.1016\/j.semarthrit.2020.06.015_bib0132","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1002\/art.24128","article-title":"Investigation of association of the IL12B and IL23R genes with psoriatic arthritis","volume":"58","author":"Filer","year":"2008","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.06.015_bib0133","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/sj.jid.5701255","article-title":"Polymorphisms of the IL12B and IL23R genes are associated with psoriasis","volume":"128","author":"Nair","year":"2008","journal-title":"J. Investig. Dermatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.015_bib0134","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","article-title":"A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am. J. Hum. Genet"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.015_bib0135","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/1744666X.2019.1564039","article-title":"Association of TNF, IL12, and IL23 gene polymorphisms and psoriatic arthritis: meta-analysis","volume":"15","author":"Loures","year":"2019","journal-title":"Expert Rev. Clin. Immunol"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.015_bib0136","doi-asserted-by":"crossref","first-page":"128","DOI":"10.5021\/ad.2015.27.2.128","article-title":"TNF, IL12B, and IFNG gene polymorphisms in serbian patients with psoriasis","volume":"27","author":"Popadic","year":"2015","journal-title":"Ann Dermatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.015_bib0137","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/jid.2008.233","article-title":"Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis","volume":"129","author":"H\u00fcffmeier","year":"2009","journal-title":"J. Investig. Dermatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.06.015_bib0138","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3109\/14397595.2016.1157282","article-title":"Relationship between the IL12B (rs3212227) gene polymorphism and susceptibility to multiple autoimmune diseases: a meta-analysis","volume":"26","author":"Li","year":"2016","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0139","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/iji.12160","article-title":"Pro\u2010and anti\u2010inflammatory cytokine gene single\u2010nucleotide polymorphisms in inflammatory bowel disease","volume":"42","author":"L\u00f3pez","year":"2015","journal-title":"Int. J. Immunogenet"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0140","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.humimm.2011.03.018","article-title":"Association of single nucleotide polymorphisms in interleukin 12 (IL-12A and -B) with asthma in a Chinese population","volume":"72","author":"Chen","year":"2011","journal-title":"Hum Immunol"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.015_bib0141","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2567.2011.03522.x","article-title":"Interleukin\u201023: as a drug target for autoimmune inflammatory diseases","volume":"135","author":"Tang","year":"2012","journal-title":"Immunology"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.06.015_bib0142","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/07853890.2011.577093","article-title":"I.nterleukin-23: a key cytokine in inflammatory diseases","volume":"43","author":"Duvallet","year":"2011","journal-title":"Ann. Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.015_bib0143","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/14397595.2014.964823","article-title":"The rs7517847 polymorphism in the IL-23R gene is associated with gout in a Chinese Han male population","volume":"25","author":"Liu","year":"2015","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0144","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cca.2017.11.038","article-title":"Interleukin-23 receptor polymorphism (rs10889677 A\/C) in ankylosing spondylitis: meta-analysis in Caucasian and Asian populations","volume":"477","author":"Han","year":"2018","journal-title":"Clinica Chimica Acta"},{"issue":"1115","key":"10.1016\/j.semarthrit.2020.06.015_bib0145","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/postgradmedj-2018-135665","article-title":"Association between cytokine gene polymorphisms and ankylosing spondylitis susceptibility: a systematic review and meta-analysis","volume":"94","author":"Xia","year":"2018","journal-title":"Postgrad. Med. J"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.015_bib0146","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00393-018-0472-z","article-title":"Associations between interleukin-23R polymorphisms and ankylosing spondylitis susceptibility: an updated meta-analysis","volume":"78","author":"Lee","year":"2019","journal-title":"Z Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0147","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11033-012-2068-z","article-title":"Marked diversity of IL23R gene haplotype variants in rheumatoid arthritis comparing with Crohn's disease and ankylosing spondylitis","volume":"40","author":"Szabo","year":"2013","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0148","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3899\/jrheum.110613","article-title":"Association of IL-12B genetic polymorphism with the susceptibility and disease severity of ankylosing spondylitis","volume":"39","author":"Wong","year":"2012","journal-title":"J. Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0149","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-3083.2009.02265.x","article-title":"Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sj\u00f6gren syndrome in Hungarian population samples","volume":"70","author":"Safrany","year":"2009","journal-title":"Scand. J. Immunol"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0150","doi-asserted-by":"crossref","first-page":"e910","DOI":"10.7717\/peerj.910","article-title":"Association between rs7517847 and rs2201841 polymorphisms in IL-23 receptor gene and risk of ankylosing spondylitis: a meta-analysis","volume":"3","author":"Xu","year":"2015","journal-title":"PeerJ"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.06.015_bib0151","doi-asserted-by":"crossref","first-page":"8987","DOI":"10.1007\/s11033-012-1768-8","article-title":"Association of interleukin 23 receptor gene polymorphisms (rs10489629, rs7517847) with rheumatoid arthritis in European population: a meta-analysis","volume":"39","author":"Zhai","year":"2012","journal-title":"Mol. Biol. Rep"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.015_bib0152","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/ard.2007.072819","article-title":"et al. Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis","volume":"67","author":"Farag\u00f3","year":"2008","journal-title":"Ann. Rheum. Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0153","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/annrheumdis-2011-200591","article-title":"Replication of association of the interleukin 23 receptor rs1343151 variant with rheumatoid arthritis in Caucasian sample sets","volume":"71","author":"Chen-Xu","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.015_bib0154","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.clinre.2014.10.009","article-title":"Interleukin-23 receptor genetic polymorphisms and ulcerative colitis susceptibility: a meta-analysis","volume":"39","author":"Liu","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.015_bib0155","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.18632\/oncotarget.13607","article-title":"IL-23R mutation is associated with ulcerative colitis: a systemic review and meta-analysis","volume":"8","author":"Peng","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.015_bib0156","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ng.275","article-title":"Ulcerative colitis\u2013risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study","volume":"41","author":"Silverberg","year":"2009","journal-title":"Nat. Genet"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0157","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/539461","article-title":"IL23R and IL12B SNPs and haplotypes strongly associate with Crohn's disease risk in a New Zealand population","author":"Ferguson","year":"2010","journal-title":"Gastroenterol Res Pract"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.06.015_bib0158","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00011-010-0171-y","article-title":"Interleukin-23 receptor genetic polymorphisms and Crohn's disease susceptibility: a meta-analysis","volume":"59","author":"Li","year":"2010","journal-title":"Inflamm. Res"},{"issue":"29","key":"10.1016\/j.semarthrit.2020.06.015_bib0159","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.3748\/wjg.14.4643","article-title":"Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult-and pediatric-onset inflammatory bowel disease in Italy","volume":"14","author":"Latiano","year":"2008","journal-title":"World J. Gastroenterol"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.06.015_bib0160","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/ibd.20180","article-title":"Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype","volume":"13","author":"Cummings","year":"2007","journal-title":"Inflamm. Bowel Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.015_bib0161","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3892\/ijmm.2010.591","article-title":"IL23R, NOD2\/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes","volume":"27","author":"Lauriola","year":"2011","journal-title":"Int. J. Mol. Med"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0162","doi-asserted-by":"crossref","first-page":"18584","DOI":"10.1038\/srep18584","article-title":"Association of Interleukin-23 receptor gene polymorphisms with susceptibility to Crohn's disease: a meta-analysis","volume":"5","author":"Xu","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.015_bib0163","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00011-012-0566-z","article-title":"Difference of interleukin-23 receptor gene haplotype variants in ulcerative colitis compared to Crohn's disease and psoriasis","volume":"62","author":"Safrany","year":"2013","journal-title":"Inflamm. Res"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.06.015_bib0164","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/ibd.20512","article-title":"Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene\u2013gene interactions","volume":"14","author":"Okazaki","year":"2008","journal-title":"Inflamm. Bowel Dis"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.06.015_bib0165","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/ced.12400","article-title":"Association of interleukin\u201023 receptor gene polymorphism with Beh\u00e7et disease","volume":"39","author":"Yalcin","year":"2014","journal-title":"Clin. Exp. Dermatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.015_bib0166","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/gene.2008.16","article-title":"IL23R: a susceptibility locus for celiac disease and multiple sclerosis?","volume":"9","author":"Nunez","year":"2008","journal-title":"Genes Immun"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.06.015_bib0167","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/ard.2003.015743","article-title":"Severe gouty arthritis refractory to anti-inflammatory drugs: treatment with anti-tumour necrosis factor \u03b1 as a new therapeutic option","volume":"63","author":"Tausche","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0168","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.phrs.2016.11.025","article-title":"Transmembrane TNF-alpha reverse signaling leading to TGF-beta production is selectively activated by TNF targeting molecules: therapeutic implications","volume":"115","author":"Szondy","year":"2017","journal-title":"Pharmacol. Res"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.06.015_bib0169","first-page":"573","article-title":"Soluble tumor necrosis factor receptor in serum of patients with arthritis","volume":"96","author":"Lee","year":"1997","journal-title":"J. Formos. Med. Assoc"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.06.015_bib0170","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1172\/JCI115142","article-title":"Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution","volume":"87","author":"Giovine","year":"1991","journal-title":"J. Clin. Investig"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0171","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/eji.201545798","article-title":"Transmembrane TNF\u2010\u03b1 is sufficient for articular inflammation and hypernociception in a mouse model of gout","volume":"46","author":"Amaral","year":"2016","journal-title":"Eur. J. Immunol"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0172","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/art.1780400525","article-title":"Endothelial activation in monosodium urate monohydrate crystal-induced inflammation: in vitro and in vivo studies on the roles of tumor necrosis factor alpha and interleukin-1","volume":"40","author":"Chapman","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.015_bib0173","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/14397595.2017.1369924","article-title":"TNF-\u03b1 potentiates uric acid-induced interleukin-1 \u03b2 (IL-1 \u03b2) secretion in human neutrophils","volume":"28","author":"Yokose","year":"2018","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0174","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1186\/s40064-016-3197-y","article-title":"TNF-\u03b1 gene polymorphisms and expression","volume":"5","author":"El-Tahan","year":"2016","journal-title":"Springerplus"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.06.015_bib0175","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/hmg\/8.8.1443","article-title":"A common functional polymorphism (C\u2192 A substitution at position\u2212 863) in the promoter region of the tumour necrosis factor-\u03b1 (TNF-\u03b1) gene associated with reduced circulating levels of TNF-\u03b1","volume":"8","author":"Skoog","year":"1999","journal-title":"Hum. Mol. Genet"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.06.015_bib0176","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/rheumatology\/keu223","article-title":"Steroid-resistant remitting seronegative symmetrical synovitis with pitting oedema associated with gout treated with etanercept","volume":"53","author":"Mehta","year":"2014","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.015_bib0177","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00296-005-0617-7","article-title":"Successful treatment of chronic tophaceous gout with infliximab (Remicade)","volume":"26","author":"Fiehn","year":"2006","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/j.semarthrit.2020.06.015_bib0178","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.4049\/jimmunol.0802812","article-title":"Monocyte chemoattractant protein-1 (MCP-1), not MCP-3, is the primary chemokine required for monocyte recruitment in mouse peritonitis induced with thioglycollate or zymosan A","volume":"183","author":"Takahashi","year":"2009","journal-title":"J. Immunol"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.015_bib0179","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interferon Cytokine Res"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.015_bib0180","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/rheumatology\/kes326","article-title":"Hyperuricaemia elevates circulating CCL2 levels and primes monocyte trafficking in subjects with inter-critical gout","volume":"52","author":"Grainger","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2020.06.015_bib0181","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.imlet.2017.06.011","article-title":"CCL2 promoter hypomethylation is associated with gout risk in Chinese Han male population","volume":"190","author":"Li","year":"2017","journal-title":"Immunol. Lett"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.015_bib0182","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00296-014-3102-3","article-title":"The CC chemokine ligand 2 (CCL2) polymorphism \u22122518A\/G is associated with gout in the Chinese Han male population","volume":"35","author":"Sun","year":"2015","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.015_bib0183","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.0022-202X.2004.23512.x","article-title":"The-2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis","volume":"124","author":"Karrer","year":"2005","journal-title":"J. Investig. Dermatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.06.015_bib0184","doi-asserted-by":"crossref","first-page":"e72732","DOI":"10.1371\/journal.pone.0072732","article-title":"Gender-specific effects of genetic variants within Th1 and Th17 cell-mediated immune response genes on the risk of developing rheumatoid arthritis","volume":"8","author":"Caliz","year":"2013","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.06.015_bib0185","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/ajg.2010.4","article-title":"The\u2212 A2518G Polymorphism of Monocyte Chemoattractant Protein-1 Is Associated With Crohn's Disease","volume":"105","author":"Palmieri","year":"2010","journal-title":"Am. J. Gastroenterol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220301918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220301918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:06:15Z","timestamp":1758733575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017220301918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":185,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0049017220301918"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.06.015","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in our understanding of gout as an auto-inflammatory disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}